Edition:
United Kingdom

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

2.06USD
8:59pm GMT
Change (% chg)

$0.03 (+1.48%)
Prev Close
$2.03
Open
$2.06
Day's High
$2.10
Day's Low
$1.99
Volume
271,772
Avg. Vol
455,795
52-wk High
$3.58
52-wk Low
$1.50

Chart for

About

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI)... (more)

Overall

Beta: 1.22
Market Cap(Mil.): $454.30
Shares Outstanding(Mil.): 118.31
Dividend: --
Yield (%): --

Financials

  AVEO.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.56 -- --
ROI: -166.61 9.01 14.96
ROE: -- 10.15 16.52

Earnings vs. Estimates